Amgen To Webcast Investor Meeting At 55th Annual Meeting Of The American Society Of Clinical Oncology (ASCO)

THOUSAND OAKS, Calif., May 29, 2019 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will host a webcast investor meeting at ASCO 2019 on Monday, June 3 at 6:30 p.m. CT. David M. Reese, M.D., executive vice president of Research and Development at Amgen, along with members of Amgen's clinical development team and clinical investigators, will participate at the investor meeting to discuss Amgen's oncology program and data presented at ASCO 2019 including clinical data being presented for the Company's KRAS G12C inhibitor AMG 510 and BiTE® molecules AMG 420 and AMG 212.   Live audio of the investor meeting will be broadcast over the internet simultaneously and will be available to members of the news med...
Source: Amgen News Release - Category: Pharmaceuticals Tags: Uncategorized Source Type: news